Psychiatric diseases, notably major depression, are associated with imbalance of excitatory and inhibitory neurotransmission within the prefrontal cortex (PFC) and related limbic brain circuitry. In many cases these illnesses are precipitated or exacerbated by chronic stress, which also alters excitatory and inhibitory neurotransmitter systems. Notably, exposure to repeated uncontrollable stress causes persistent changes in the synaptic integrity and function of the principal glutamatergic excitatory neurons in the PFC, characterized by neuronal atrophy and loss of synaptic connections. This can lead to dysfunction of the PFC circuitry that is necessary for execution of adaptive behavioral responses. In addition, an emerging literature shows that chronic stress causes extensive alterations of GABAergic inhibitory circuits in the PFC, leading to the hypothesis that deficits in inhibitory neurotransmission contribute to changes in PFC neuronal excitability and cognitive impairments. Here we review evidence in rodent and human, which points to the mechanisms underlying stressinduced alterations of GABA transmission in the PFC, and its relevance to circuit dysfunction in mood and stress related disorders. These findings suggest that alterations of GABA interneurons and inhibitory neurotransmission play a causal role in the development of stress-related neurobiological illness, and could identify a new line of GABA related therapeutic targets.
Introduction
The prefrontal cortex (PFC) plays a central role in stress adaptation [1, 2] , and impaired circuitry and function of PFC subregions are pathological features of many psychiatric illnesses [3, 4] . Clinical research has consistently reported that depression and other stress-related illnesses are associated with decreased volume, neuronal atrophy, and altered connectivity of the PFC [5] . These findings in humans are supported by rodent studies demonstrating that chronic stress exposure produces a number of alterations in the PFC, including dendritic atrophy and synapse loss [6,7 ,8] , as well as loss of neurotrophic factor support. These core features of rodent stress studies have led to the hypothesis that reductions in neurotrophic factor expression result in neuronal and synaptic morphological deficits observed in human subjects (for review see [9] ). A related hypothesis suggests that an imbalance in excitatory and inhibitory neurotransmission occurring directly through deficient GABAergic inhibitory signaling in the PFC could account for the outcomes observed in human subjects and rodent models.
In this paper, we review the literature and evidence demonstrating GABA dysfunction in human depression as well as in preclinical rodent stress studies. We then point to recent examples from studies in transgenic mice that shed light on how GABA interneuron subtypes can balance cortical transmission and ultimately shape top down control of depression-like and anxiety-like behaviors. Finally, based on recent studies, we discuss how targeting intra-cortical GABA inhibition in the PFC can provide important therapeutic targets for the treatment of depression and other psychiatric illness.
GABAergic neurotransmission in the PFC
The PFC is comprised of a heterogeneous population of neurons, including the glutamatergic principal excitatory neurons and GABAergic inhibitory interneurons. GABAergic interneurons comprise approximately 25% of the neurons within the neocortex [10] , and are responsible for inhibitory control via activation of ionotropic GABA A receptors, which gate chloride entry into neurons [10] . GABA transmission is also mediated through metabotropic GABA B receptors, which are generally thought to be active at higher GABA levels and can act as autoreceptors on presynaptic GABA terminals, as well as provide direct inhibition on principal neurons [11] . GABAergic interneurons differ considerably in their morphology, electrophysiological properties, connectivity, and expression of neuropeptides and calcium-binding proteins [10] . There are at least 20 different subtypes 
